Effects of Vitamin E on seizure frequency, electroencephalogram findings, and oxidative stress status of refractory epileptic patients


1 Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran

2 Station of Health Research, National Institute of Health Research, Tehran University of Medical Sciences, Tehran, Iran

3 Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran


Background: Oxidative stress has been a frequent finding in epileptic patients receiving antiepileptic drugs (AEDs). In this study, the influence of Vitamin E on the antiseizure activity and redox state of patients treated with carbamazepine, sodium valproate, and levetiracetam has been investigated.
Materials and Methods: This double-blind, placebo-controlled trial was carried out on 65 epileptic patients with chronic antiepileptic intake. The subjects received 400 IU/day of Vitamin E or placebo for 6 months. Seizure frequency, electroencephalogram (EEG), and redox state markers were measured monthly through the study.
Results: Total antioxidant capacity, catalase and glutathione were significantly higher in Vitamin E received group compared with controls (P < 0.05) whereas malodialdehyde levels did not differ between two groups (P < 0.07). Vitamin E administration also caused a significant decrease in the frequency of seizures (P < 0.001) and improved EEG findings (P = 0.001). Of 32 patients in case group, the positive EEG decreased in 16 patients (50%) whereas among 33 patients in control group only 4 patients (12.1%) showed decreased positive EEG.
Conclusion: The results of this preliminary study indicate that coadministration of antioxidant Vitamin E with AEDs improves seizure control and reduces oxidative stress.


Aguiar CC, Almeida AB, Araújo PV, de Abreu RN, Chaves EM, do Vale OC, et al. Oxidative stress and epilepsy: Literature review. Oxid Med Cell Longev 2012;2012:795259.  Back to cited text no. 1
Nemade ST, Melinkeri R. Effect of antiepileptic drugs on antioxidant status epilepsy. Curr Neurobiol 2010;1:109-12.  Back to cited text no. 2
Schulpis KH, Lazaropoulou C, Regoutas S, Karikas GA, Margeli A, Tsakiris S, et al. Valproic acid monotherapy induces DNA oxidative damage. Toxicology 2006;217:228-32.  Back to cited text no. 3
Yis U, Seçkin E, Kurul SH, Kuralay F, Dirik E. Effects of epilepsy and valproic acid on oxidant status in children with idiopathic epilepsy. Epilepsy Res 2009;84:232-7.  Back to cited text no. 4
Aycicek A, Iscan A. The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children. Eur Neurol 2007;57:65-9.  Back to cited text no. 5
Boon NA. Davidson's Principles and Practice of Medicine. 20th ed. USA: Churchill Livingstone, Elsevier; 2006.  Back to cited text no. 6
Fisher RS van Emde Boas W, Blume W, Elger C, Genton P, Lee P, et al. Epileptic seizures and epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46:470-2.  Back to cited text no. 7
Ahlen L. The effect of sodium valproat on folat levels, transmethylation, homocysteine and oxidative stress: Is there a link with neurodegeneration and continued seizure? Nutr Pract 2011;12:36-60.  Back to cited text no. 8
Vega Rasgado L, Ceballos Reyes G, Vega-Diaz M. Anticonvulsant Drugs, Oxidative Stress and Nitric Oxide. In Proceeding Western Pharmacology Society; 2011.  Back to cited text no. 9
Thanoon IA, Pachachi OA, Al-Sheikh MM. Effect of carbamazpin on serum leptin, insulin levels and oxidative stress in epileptic patients. Ann Coll Med Mosul 2012;38:40-5.  Back to cited text no. 10
Ogunmekan AO, Hwang PA. A randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopheryl acetate (Vitamin E), as add-on therapy, for epilepsy in children. Epilepsia 1989;30:84-9.  Back to cited text no. 11
Nazıroğlu M. Role of selenium on calcium signaling and oxidative stress-induced molecular pathways in epilepsy. Neurochem Res 2009;34:2181-91.  Back to cited text no. 12
Verrotti A, Scardapane A, Franzoni E, Manco R, Chiarelli F. Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Res 2008;78:171-7.  Back to cited text no. 13
Kovalenko VM, Kryzhanovskii GN, Kovalenko VS, Pronina IG, Nikushkin EV. Alpha-tocopherol in the complex treatment of several forms of epilepsy. Zh Nevropatol Psikhiatr Im S S Korsakova 1984;84:892-7.  Back to cited text no. 14
Ebrahimi H, Shafa M, Hakimzadeh Asl S. Prevalence of active epilepsy in Kerman, Iran: A house based survey. Acta Neurol Taiwan 2012;21:115-24.  Back to cited text no. 15
Mohammadi MR, Ghanizadeh A, Davidian H, Mohammadi M, Norouzian M. Prevalence of epilepsy and comorbidity of psychiatric disorders in Iran. Seizure 2006;15:476-82.  Back to cited text no. 16
Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: The FRAP assay. Anal Biochem 1996;239:70-6.  Back to cited text no. 17
Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 1991;196:143-51.  Back to cited text no. 18
Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978;90:37-43.  Back to cited text no. 19
Asif M. Role of various Vitamins in the patients with epilepsy. IJPR 2013;3:34.  Back to cited text no. 20
Higashi A, Tamari H, Ikeda T, Ohtani Y, Matsukura M, Miyoshino S, et al. Serum Vitamin E concentration in patients with severe multiple handicaps treated with anticonvulsants. Pediatr Pharmacol (New York) 1980;1:129-34.  Back to cited text no. 21
Sudha K, Rao AV, Rao A. Oxidative stress and antioxidants in epilepsy. Clin Chim Acta 2001;303:19-24.  Back to cited text no. 22
Veinbergs I, Mallory M, Sagara Y, Masliah E. Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice. Eur J Neurosci 2000;12:4541-6.  Back to cited text no. 23
deficits and dendritic alterations in aged apolipoprotein E-deficient mice. Eur. J. Neurosci 2000;12:45414-16.  Back to cited text no. 24
Levy SL, Burnham WM, Hwang PA. An evaluation of the anticonvulsant effects of Vitamin E. Epilepsy Res 1990;6:12-7.  Back to cited text no. 25
Raju GB, Behari M, Prasad K, Ahuja GK. Randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopherol (Vitamin E) as add-on therapy in uncontrolled epilepsy. Epilepsia 1994;35:368-72.  Back to cited text no. 26
Kaya M, Cimen V, Kalayci R, Kucuk M, Gurses C, Arican N, et al. Catalase and alpha-tocopherol attenuate blood-brain barrier breakdown in pentylenetetrazole-induced epileptic seizures in acute hyperglycaemic rats. Pharmacol Res 2002;45:129-33.  Back to cited text no. 27
Tomé AR, Feng D, Freitas RM. The effects of alpha-tocopherol on hippocampal oxidative stress prior to in pilocarpine-induced seizures. Neurochem Res 2010;35:580-7.  Back to cited text no. 28
Harma M, Harma M, Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003;133:563-6.  Back to cited text no. 29
Levy SL, Burnham WM, Bishai A, Hwang PA. The anticonvulsant effects of Vitamin E: A further evaluation. Can J Neurol Sci 1992;19:201-3.  Back to cited text no. 30
Kim HC, Choi DY, Jhoo WK, Lee DW, Koo CH, Kim C. Aspalatone, a new antiplatelet agent, attenuates the neurotoxicity induced by kainic acid in the rat. Life Sci 1997;61:PL 373-81.  Back to cited text no. 31
Jain SK, McVie R, Jaramillo JJ, Palmer M, Smith T, Meachum ZD, et al. The effect of modest Vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients. Lipids 1996;31 Suppl:S87-90.  Back to cited text no. 32
Tayebi Khosroshahi H, Habibi Asl B, Habibzadeh A, Chaichi P, Ghanbarpour A, Hossein Badie A. Comparison of Vitamin E and L-carnitine, separately or in combination in patients with intradialytic complications. Nephrourol Mon 2013;5:862-5.  Back to cited text no. 33
Araoud M, Neffeti F, Douki W, Khaled L, Najjar MF, Kenani A, et al. Toxic effects of methamidophos on paraoxonase 1 activity and on rat kidney and liver and ameliorating effects of alpha-tocopherol. Environ Toxicol 2014.  Back to cited text no. 34
Singh U, Otvos J, Dasgupta A, de Lemos JA, Devaraj S, Jialal I. High-dose alpha-tocopherol therapy does not affect HDL subfractions in patients with coronary artery disease on statin therapy. Clin Chem 2007;53:525-8.  Back to cited text no. 35
Martinc B, Grabnar I, Vovk T. Antioxidants as a preventive treatment for epileptic process: A review of the current status. Curr Neuropharmacol 2014;12:527-50.  Back to cited text no. 36